¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"second wind"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • second messenger
    Á¦ÀÌÀü·É(¡­îîÖµ), Á¦À̸޽ÅÀú(¡­)
  • second middle cuneiform bone ; os cuneiforme intermedium
    Áß°£½û±â°ñ, Áß°£¼³»ó°ñ.
  • second milk molar
    Á¦ÀÌÀ¯±¸Ä¡(ð¯ì£ êáÏ¿öÍ).
  • second molar =posteriory cheek tooth
    µÑ°¾î±Ý´Ï, Á¦À̴뱸ġ(ð¯ì£ÓÞÏ¿ öÍ).
  • second opinion
    Á¦2ÀÇ°ß Á¦½Ã ÇÁ·Î±×·¥.
  • second order neuron
    Á¦ÀÌ´º¿ì·Ð.
  • second order neuron
    Á¦ÀÌ´º¿ì·Ð.
  • second order reaction
    ÀÌÂ÷¹ÝÀÀ.
  • second pharyngeal arch
    µÑ°ÀεαÁÀÌ
  • second pharyngeal arch
    µÑ°ÀεαÁÀÌ (µÑ°¾Æ°¡¹Ì±ÁÀÌ)
  • second pharyngeal pouch
    µÑ°ÀεÎÁÖ¸Ó´Ï
  • second polar body
    µÑ°±ØÃ¼, Á¦À̱ØÃ¼(ð¯ì£Ð¿ô÷).
  • second polar body
    µÑ°±ØÃ¼
  • second posterior intercostal artery
    µÑ°µÚ°¥ºñ»çÀ̵¿¸Æ
  • second pouch
    µÑ°ÁÖ¸Ó´Ï
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
A2 aortic second sound
A2-OS aortic second sound, opening snap
AII acute intestinal infection; second meiotic anaphase
A x s ampere per second
C2a activated second component of complement
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SMN Second Malignant Neoplasm
SHG Second harmonic generation
SLO Second look operation
SPT second primary tumor
SLL Second-look laparotomy
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
second law of thermodynamics <physics> All of the chemical and physical processes in a closed system tend to drive that system toward maximum entropy.
Clausius statement: No device can operate in a cycle and allow heat to transfer from a colder body to a hotter body unless other compensating activities are taking place.
Kelvin-Planck statement: no device can operate in a constant-temperature cycle and convert the heat it receives into work, unless other other compensating activities are taking place.
(09 Oct 1997)
second line chemotherapy <oncology> Chemotherapy given for a tumour which has already failed to respond to a first chemotherapy regimen (called first line).
(16 Dec 1997)
second-look operation Exploratory celiotomy within a year after apparently curative resection of intra-abdominal cancer, in patients with no sign or symptom of recurrence, to resect an occult tumour if present.
(05 Mar 2000)
second meiotic division The second of two consecutive divisions of the nucleus of an eukaryotic cell during the process of meiosis. It includes the following stages of meiosis: prophase II, metaphase II, anaphase II, and telophase II.
(09 Oct 1997)
second messenger <molecular biology> In many hormone sensitive systems the systemic hormone does not enter the target cell but binds to a receptor and indirectly affects the production of another molecule within the cell, this diffuses intracellularly to the target enzymes or intracellular receptor to produce the response. This intracellular mediator is called the second messenger.
Examples include cyclic AMP, cyclic GMP, IP3 and diacylglycerol.
(18 Nov 1997)
second messenger systems Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.
(12 Dec 1998)
second molar Seventh permanent or fifth deciduous tooth in the maxilla and mandible on either side of the midsagittal plane of the head following the arch form.
(05 Mar 2000)
second-order conditioning The use of a previously successfully conditioned stimulus as the unconditioned stimulus for further conditioning.
(05 Mar 2000)
second-order kinetics A term describing the reaction rate of a chemical reaction in which the rate is proportional to the product of the concentrations (in moles) of two of the reactants (also called bimolecular kinetics), or to the square of the molar concentration of the reactant if there is only one. Such a reaction might have an equation like rate = k[A][B] or rate = k[A]2, where k is the reaction rate constant, [A] is the concentration of reactant A, and [B] is the concentration of reactant B.
(09 Oct 1997)
second parallel pelvic plane The plane extending from the middle of the posterior surface of the pubic symphysis to the junction of the second and third sacral vertebrae, and laterally passing through the ischial bones over the middle of the acetabulum.
Synonym: second parallel pelvic plane, wide plane.
(05 Mar 2000)
second set rejection An accelerated rejection of a transplant that occurs when an individual has been previously sensitised to the graft.
(05 Mar 2000)
second sight 1. <ophthalmology> Improved near vision in the aged as a result of increased refractivity of the nucleus of the lens causing myopia.
Synonym: senile lenticular myopia.
2. The power of discerning what is not visible to the physical eye, or of foreseeing future events. Such as are of a disastrous kind, the capacity of a seer or prophetic vision.
Source: Websters Dictionary
(01 Mar 1998)
second signaling system <psychology> Pavlovian term for speech in which words are considered to be the second signals capable of producing conditioned responses.
(05 Mar 2000)
second sound The second sound heard on auscultation of the heart; signifies the beginning of diastole and is due to closure of the semilunar valves.
Synonym: second sound.
(05 Mar 2000)
second-stability region <radiobiology> A high pressure region where the plasma becomes stable to the pressure-gradient-driven ballooning instability.
The plasma is stable in the limit of small pressure gradients, becomes unstable at some intermediate pressure, and then becomes stable again at still higher pressures. Tokamaks operating in the second-stability region would be more attractive because the higher pressures (beta) would provide more fusion reactivity per unit volume of plasma, allowing smaller reactors to be built.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • second fiddle
    Á¦ 2 ¹ÙÀ̾ó¸°;º¸Á¿ª
  • second floor
    2Ãþ;(¿µ)3Ãþ
  • second generation
    2¼¼ÀÇ;(ÄÄÇ»ÅÍ)Á¦ 2¼¼´ëÀÇ(°íü¼ÒÀÚ ¹ÝµµÃ¼¸¦ ¾²´Â ÄÄÇ»ÅÍ¿¡ ´ëÇØ)
  • second guess
    (¹Ì)°á°ú¸¦ ¾Æ ÈÄ¿¡ ºñÆÇ(¼öÁ¤)ÇÏ´Ù;¿¹¾ðÇÏ´Ù(predit);(³²ÀÇ ¸¶À½À»)¹Ì¸® ¾Ë´Ù
  • second hand
    (½Ã°èÀÇ)ÃÊħ
  • second in command
    ºÎ»ç·É°ü;Â÷Àå
  • second lieutenant
    ¼ÒÀ§
  • second nature
    Á¦ 2ÀÇ Ãµ¼º(½À¼º)
  • second pair
    (¿µ)3ÃþÀÇ: a~front(back)3ÃþÀÇ ¾Õ(µÞ) ¹æ
  • second papers
    Á¦ 2Â÷ ¼­·ù(¹Ì±¹¿¡ ±ÍÈ­ÇÏ´Â ÃÖÁ¾ ½Åû¼­)
  • second person
    Á¦ 2ÀÎĪ
  • second rate
    2·ùÀÇ;2µîǰ;...¸¸ ¸øÇÑ
  • second rate
    2·ùÀÇ;¿­µîÇÑ;Æò¹üÇÑ
  • second rater
    2·ùÀÇ »ç¶÷(°Í);Æò¹üÇÑ »ç¶÷ (°Í);ÇÏÀÝÀº »ç¶÷(°Í)
  • second sight
    õ¸®¾È;¼±°ßÁö¸í
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á